Tarveda: Tarveda Therapeutics and SciClone Pharmaceuticals Expand Partnership by Entering into a License Agreement for HSP90-PI3K Miniature Drug Conjugates in Greater China

(marketscreener.com) Tarveda Therapeutics, Inc. , a clinical stage biopharmaceutical company developing a new class of potent and selective precision oncology medicines, which it refers to as Pentarin® miniature drug conjugates, today announced that the company has entered into a collaboration and license agreement with SciClone Pharmaceuticals Limited ....https://www.marketscreener.com/news/latest/Tarveda-Therapeutics-and-SciClone-Pharmaceuticals-Expand-Partnership-by-Entering-into-a-License-Agre--36447027/?utm_medium=RSS&utm_content=20210916